Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder.

The trial will compare active TQL block versus placebo TQL block after said operation.

The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy

NCT02712151

Pain, Postoperative

WITHDRAWN PHASE3

Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-cholecystectomy Analgesia

NCT03323684

Laparoscopic Cholecystectomy

COMPLETED NA

Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery

NCT02185716

Cholecystectomy, Laparoscopic Pain, Postoperative

COMPLETED PHASE4

The Analgesic Efficacy of Transversus Abdominis Plane Block After Laparoscopic Cholecystectomy

NCT01046071

Laparoscopic Cholecystectomy

COMPLETED PHASE4

Analgesic Effect of Quadratus Lumborum Block Application After Laparoscopic Cholecystectomy Surgery

NCT03308955

Cholecystectomy Postoperative Pain Nerve Block

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholecystitis Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo TQL block

30 ml single shot TQL block with saline 0,9%

Group Type SHAM_COMPARATOR

saline

Intervention Type DRUG

Active TQL block

30 ml single shot TQL block with ropivacaine 0,75%

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine

Intervention Type DRUG

saline

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

naropin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* scheduled for elective laparoscopic cholecystectomy
* received oral and written information about the trial
* American Society of Anaethesiologists (ASA) classification 1-3
* NRS score \> 3 upon arrival at the PACU area

Exclusion Criteria

* Cannot cooperate
* Does not speak or understand Danish
* Allergy towards drugs used in the trial
* Large daily consumption of opioids
* Known alcohol og medicin abuse
* Difficult or impossible by ultrasound to visualise the intended nerve/tissue structures necessary to perform block
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No